Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07344948
EARLY_PHASE1

Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia

Sponsor: Neurosterix

View on ClinicalTrials.gov

Summary

This study will assess the safety, tolerability, and pharmacokinetics of NTX-253 following oral administration in both healthy adult participants as well as adult participants with stable schizophrenia.

Official title: A First in Human, Phase 1/1b Study of Single and Multiple Ascending Dosing Administration of NTX110253 in Healthy Participants and Participants With Stable Schizophrenia

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

73

Start Date

2025-10-03

Completion Date

2026-05

Last Updated

2026-01-15

Healthy Volunteers

Yes

Interventions

DRUG

NTX-253

Oral Capsule

DRUG

Placebo

Oral capsule

Locations (1)

Collaborative Neuroscience Research, LLC - CenExel

Los Alamitos, California, United States